SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-036358
Filing Date
2023-10-05
Accepted
2023-10-05 16:10:15
Documents
14
Period of Report
2023-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38049
2 ex10-1.htm EX-10.1 31889
3 ex10-1_001.jpg GRAPHIC 1175
  Complete submission text file 0001493152-23-036358.txt   254098

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT shph-20231001.xsd EX-101.SCH 3030
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT shph-20231001_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT shph-20231001_pre.xml EX-101.PRE 22369
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3433
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 231311449
SIC: 2834 Pharmaceutical Preparations